These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1447705)

  • 21. In vivo concentrations of kinins and angiotensins.
    Shimamoto K; Nakagawa M; Iimura O
    Horm Metab Res Suppl; 1990; 22():75-9. PubMed ID: 2143993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between radioreceptor assay and radioimmunoassay for the determination of dihydroergotoxine in rabbit plasma samples.
    Shimada N; Ushioda K; Nagatsuka S; Ueda T; Yokoshima T
    J Immunol Methods; 1983 Dec; 65(1-2):191-8. PubMed ID: 6655239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibition increases collateral-dependent muscle blood flow.
    Yang HT; Terjung RL
    J Appl Physiol (1985); 1993 Jul; 75(1):452-7. PubMed ID: 8397181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoassay for trimeprazine in human plasma.
    McKay G; Rauw GA; Stonkus MD; Dulos RA; Gedir RG; Hawes EM; Midha KK
    J Pharmacol Methods; 1984 Oct; 12(3):203-11. PubMed ID: 6536824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-warfarin antibody preparation and its characterization for radioimmunoassay.
    Satoh H; Hayashi M; Satoh S
    J Pharm Pharmacol; 1982 Jul; 34(7):429-33. PubMed ID: 6126538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic study of bisaramil in man.
    Gémesi L; Kapás M; Matos L
    Acta Pharm Hung; 1993 Nov; 63(6):327-33. PubMed ID: 8116453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
    Becker RH; Schölkens BA; Metzger M; Schulze KJ
    Arzneimittelforschung; 1984; 34(10B):1411-6. PubMed ID: 6097267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme immunoassay discrimination of a new angiotensin-converting enzyme (ACE) inhibitor, cilazapril, and its active metabolite.
    Tanaka H; Yoneyama Y; Sugawara M; Umeda I; Ohta Y
    J Pharm Sci; 1987 Mar; 76(3):224-7. PubMed ID: 3035170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ramipril in the elderly.
    Meyer BH; Müller FO; Badian M; Eckert HG; Hajdú P; Irmisch R; Schmidt D
    Am J Cardiol; 1987 Apr; 59(10):33D-37D. PubMed ID: 3034031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoassays of 7-hydroxymethotrexate and methotrexate.
    Bore P; Rahmani R; Cano JP; Just S; Barbet J
    Clin Chim Acta; 1984 Aug; 141(2-3):135-49. PubMed ID: 6488553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.
    Manhem PJ; Ball SG; Morton JJ; Murray GD; Leckie BJ; Fraser R; Robertson JI
    Br J Clin Pharmacol; 1985 Jul; 20(1):27-35. PubMed ID: 2992562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of the newer ACE inhibitors. A review.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1990 Sep; 19(3):177-96. PubMed ID: 2203579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of radioimmunoassays for trifluoperazine and their application to metabolic studies of the drug.
    Midha KK; Hawes EM; Rauw G; McKay G; Cooper JK; Shetty HU
    J Pharmacol Methods; 1983 Jun; 9(4):283-93. PubMed ID: 6621049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midazolam: radioimmunoassay for pharmacokinetic studies in man.
    Dixon R; Lucek R; Todd D; Walser A
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):11-20. PubMed ID: 7122996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunoassays for the enantiomeric components of indacrinone and their phenolic metabolites.
    Vyas KP; Hichens M; Mulcahy WS; Hand EL
    J Immunoassay; 1987; 8(2-3):179-201. PubMed ID: 3624493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunoassays for melatonin using an antiserum raised against a novel antigen.
    Mikami H; Terazawa K; Takatori T; Tomaru Y; Ji L; Kanamori M
    Nihon Hoigaku Zasshi; 1992 Apr; 46(2):111-6. PubMed ID: 1619806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of benazepril hydrochloride and benazeprilat in plasma by high-performance liquid chromatography/electrospray-mass spectrometry.
    Xiao W; Chen B; Yao S; Cheng Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):303-8. PubMed ID: 15639452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a radioimmunoassay for prostaglandin E2 metabolite levels in plasma.
    Demers LM; Brennecke SP; Mountford LA; Brunt JD; Turnbull AC
    J Clin Endocrinol Metab; 1983 Jul; 57(1):101-6. PubMed ID: 6853670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
    Worland PJ; Jarrott B
    J Pharm Sci; 1986 May; 75(5):512-6. PubMed ID: 3016233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A radioimmunoassay for the anticonvulsant and neuroprotective agent, MK-801.
    Hichens M; Greber TF; Vyas KP
    J Immunoassay; 1990; 11(4):477-502. PubMed ID: 2283390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.